RealTime Laboratories Launches Comprehensive Mycotoxin Test
In a significant advancement in environmental health diagnostics, RealTime Laboratories Inc. has unveiled its innovative
Mycotoxin Extensive Panel. This groundbreaking test features
31 distinct markers, making it the most comprehensive urinary mycotoxin test available today. By enhancing testing methodologies and expanding biomarker coverage, this test promises to empower practitioners and patients alike with greater insights into mold exposure and its associated health risks.
Expanding the Horizon of Mycotoxin Testing
The newly launched panel enhances the understanding of mold-related health concerns by providing practitioners with vital data derived from a single urine sample. With the inclusion of
16 new mycotoxin markers, alongside the previously measured toxins, the panel now assesses substances like
Satratoxins, Roridins, Trichothecenes, as well as newly added markers such as
Chaetoglobosin A, Citrinin, and
Fumonisins.
Enhanced Methodology for More Accurate Results
RealTime Laboratories has implemented
liquid chromatography-tandem mass spectrometry (LC-MS/MS) analysis paired with its proprietary
hydrolysis processing technology. This advanced methodology is designed to overcome challenges faced in traditional testing, including the potential for misdiagnosis due to metabolite modifications that conceal mycotoxins. The panel aims to capture a broader range of metabolites, enhancing the accuracy and reliability of results.
CEO
Jack Frausing emphasized the company's dedication to diagnostic accuracy, stating, "The expansion of our mycotoxin panel and methodologies underscores our commitment to rigorous laboratory standards and enhancing clinical decision-making."
A Comprehensive Approach to Environmental Health
As public interest in environmental health rises, especially concerning mold exposure, this extended mycotoxin panel supports clinicians in making well-informed clinical decisions. It also facilitates discussions between patients and healthcare providers regarding potential health impacts and appropriate treatment paths. By streamlining data collection into an easy-to-understand format, RealTime Labs seeks to alleviate complexities often faced by patients undergoing testing.
Integrative Testing Suites
The launch of the Mycotoxin Extensive Panel signifies an expansion of RealTime Labs' integrative testing suites, which also include the
All-Tox Profile and the
MOE-Tox Complete Profile. These profiles evaluate not only mycotoxin exposure but also environmental pollutants, heavy metals, and organic acids, allowing for a more holistic understanding of a patient's health. Consulting physician
Marjorie Peak, ND, remarked, "More comprehensive testing equips practitioners with crucial information that adds context to the patient's overall clinical picture, thus enhancing decision-making outcomes."
Accessibility for Consumers
The Mycotoxin Extensive Panel is readily available to consumers, allowing individuals to order tests directly or through healthcare provider networks. Furthermore, customers can take advantage of
HSA/FSA eligibility, making it accessible for a broader audience. As part of its commitment to public health education, RealTime Labs has also launched an
Environmental Mold and Mycotoxin Assessment (EMMA), which assesses environments for mold presence and types of mycotoxins, paralleling findings from urinary tests.
Conclusion
By combining cutting-edge technology with an expansive range of tested biomarkers, RealTime Laboratories is setting a new standard in mycotoxin testing. Their
Mycotoxin Extensive Panel represents a pivotal evolution in the field, catering to both medical professionals and patients eager to understand the complexities of mold exposure and its effects on health. To celebrate the launch, customers can use the code
'Mycotox31' for a discount on their purchase until the end of September. To learn more about RealTime Laboratories and their range of at-home tests, visit
www.realtimelab.com.